Vitro Diagnostics Inc. | Income Statement
Fiscal year is November-October. All values USD Thousands.
2012
2013
2014
2015
2017
Sales/Revenue
28.10
34.90
142.70
99.50
262.10
Cost of Goods Sold (COGS) incl. D&A
20.10
15.30
23.00
21.70
104.70
Gross Income
8.00
19.60
119.70
77.80
157.40
SG&A Expense
187.10
174.00
290.80
235.90
315.70
EBIT
179.10
154.50
171.00
158.10
295.80
Non Operating Income/Expense
-
3.20
-
-
-
Interest Expense
48.50
59.90
75.50
87.70
154.40
Pretax Income
227.70
211.20
246.50
245.90
450.20
Consolidated Net Income
227.70
211.20
246.50
245.90
450.20
Net Income
227.70
211.20
246.50
245.90
450.20
Net Income After Extraordinaries
227.70
211.20
246.50
245.90
450.20
Net Income Available to Common
227.70
211.20
246.50
245.90
450.20
EPS (Basic)
0.01
0.01
0.01
0.01
0.02
Basic Shares Outstanding
18,993.40
19,589.40
19,881.30
20,049.60
-
EPS (Diluted)
0.01
0.01
0.01
0.01
-
Diluted Shares Outstanding
18,993.40
19,589.40
19,881.30
20,049.60
-
EBITDA
159.10
139.20
153.40
142.30
293.40
Other Operating Expense
-
-
-
-
137.50
About Vitro Diagnostics
View Profile
